Resultados de búsqueda - Idris

A remark on "A non-singular dynamical system without maximal ergodic inequality" by E. H. El Abdalaoui" por Assani, Idris

Enlace del recurso

Fenofibrate shown to reduce progression of diabetic retinopathy por Iskandar Idris

Enlace del recurso

Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied por Iskandar Idris

Enlace del recurso

Tirzepatide shown to be effective at reducing sleep disturbances in patients with obstructive sleep apnoea por Iskandar Idris

Enlace del recurso

The glucagon like peptide‐1 linked to nonarteritic anterior ischemic optic neuropathy por Iskandar Idris

Enlace del recurso

Can diet and exercise intervention prevent type 2 diabetes in individuals with a high genetic risk? por Iskandar Idris

Enlace del recurso

Real world data showed that the dual GLP gip agonist, Tirzepatide is associated with lower mortality, cardiovascular events and adverse kidney events compared with GLP‐1 analogue por Iskandar Idris

Enlace del recurso

Real world study provided reassurance of the safety of GLP‐1 therapy on mental health and suicide risk por Iskandar Idris

Enlace del recurso

Increasing excess to weight loss injection shown to save thousands of lives a year por Iskandar Idris

Enlace del recurso

Precision medicine approach to detect obese people who are at high risk of developing diabetes por Iskandar Idris

Enlace del recurso

Tirzepatide shown to improve clinical outcomes for patients with heart failure with preserved ejection fraction (HFpEF) and obesity por Iskandar Idris

Enlace del recurso

Potential role of glucagon like peptide (GLP)‐1 receptor agonist to reduce risk of colorectal cancer? por Iskandar Idris

Enlace del recurso

Epigenetic changes shown to cause type 2 diabetes por Iskandar Idris

Enlace del recurso

Hybrid closed‐loop therapy significantly improved maternal glucose control during pregnancy complicated by type 1 diabetes por Iskandar Idris

Enlace del recurso

Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease por Iskandar Idris

Enlace del recurso

Extension study from DIRECT showed ongoing remission rate from type 2 diabetes in some patient following very low calorie diet at 5 years por Iskandar Idris

Enlace del recurso

Increased expression of the protein Kallistatin after weight loss induces beneficial metabolic effects: A potential new therapeutic target? por Iskandar Idris

Enlace del recurso

The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH) por Iskandar Idris

Enlace del recurso

Appropriate timing of exercise for adults with obesity including those with type 2 diabetes por Iskandar Idris

Enlace del recurso

Adults who are overweight or obese may experience greater pain intensity compared with normal weight individuals? por Iskandar Idris

Enlace del recurso